Insider Trading History of Schlesinger Michael A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Schlesinger Michael A. since 2021. This trader's CIK number is 1839441. At the time of last reporting, Schlesinger Michael A. was the EVP, GC and Secretary of Ortho Clinical Diagnostics Holdings Plc. (stock ticker symbol OCDX). Also see all insider trading activities at Ortho Clinical Diagnostics Holdings Plc.


Yearly summary of insider trading at Ortho Clinical Diagnostics Holdings Plc (OCDX) by Schlesinger Michael A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 OCDX 0 $0 218,043 $4,393,784 218,043 $1,369,310
2021 OCDX 0 $0 205,464 $4,077,739 205,464 $1,290,312


Insider trading of Ortho Clinical Diagnostics Holdings Plc (OCDX) by Schlesinger Michael A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-04-04 OCDX Option Ex 88,043 6.28 552,910
2022-04-04 OCDX Sale 88,043 18.77 1,652,214
2022-01-03 OCDX Option Ex 130,000 6.28 816,400
2022-01-03 OCDX Sale 130,000 21.09 2,741,570
2021-10-15 OCDX Option Ex 75,464 6.28 473,913
2021-10-15 OCDX Sale 75,464 19.73 1,488,980
2021-08-16 OCDX Option Ex 4,000 6.28 25,120
2021-08-16 OCDX Sale 4,000 20.03 80,112
2021-08-18 OCDX Option Ex 41,015 6.28 257,574
2021-08-18 OCDX Sale 41,015 20.14 826,001
2021-08-11 OCDX Option Ex 72,585 6.28 455,833
2021-08-12 OCDX Option Ex 8,100 6.28 50,868
2021-08-11 OCDX Sale 72,585 19.77 1,434,642
2021-08-13 OCDX Option Ex 4,300 6.28 27,004
2021-08-12 OCDX Sale 8,100 20.00 162,000
2021-08-13 OCDX Sale 4,300 20.00 86,004

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schlesinger Michael A. (EVP, GC and Secretary of Ortho Clinical Diagnostics Holdings Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.